Autosomal Dominant Polycystic Kidney Disease News and Research

RSS
Otsuka Pharmaceutical begins tolvaptan Phase 3b study in patients with ADPKD

Otsuka Pharmaceutical begins tolvaptan Phase 3b study in patients with ADPKD

Study: Pravastatin slows down growth of kidney cysts in children, young adults with ADPKD

Study: Pravastatin slows down growth of kidney cysts in children, young adults with ADPKD

Otsuka obtains regulatory approval in Japan for pharmacological treatment of ADPKD

Otsuka obtains regulatory approval in Japan for pharmacological treatment of ADPKD

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

Component of grape, citrus fruits block formation of kidney cysts

Component of grape, citrus fruits block formation of kidney cysts

Research uncovers defective process in patients with autosomal dominant polycystic kidney disease

Research uncovers defective process in patients with autosomal dominant polycystic kidney disease

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

Tolvaptan improves kidney health in polycystic kidney disease

Tolvaptan improves kidney health in polycystic kidney disease

Study highlights potential treatment that reduces kidney growth

Study highlights potential treatment that reduces kidney growth

Tolvaptan shows promise in treating autosomal dominant polycystic kidney disease

Tolvaptan shows promise in treating autosomal dominant polycystic kidney disease

Potential new drug to treat common inherited kidney disease

Potential new drug to treat common inherited kidney disease

RA drug reduces kidney cyst growth in ADPKD mouse model

RA drug reduces kidney cyst growth in ADPKD mouse model

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

Targeting activity of PKD1 may be beneficial for treatment of polycystic kidney, liver disease

New discoveries on polycystin-1 can lead to novel kidney disease treatment

New discoveries on polycystin-1 can lead to novel kidney disease treatment

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

UCSB research: Rapamycin drug, a potential treatment for ADPKD

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Researchers visualize vasculature within native liver cyst walls of human ADPKD patients

Researchers visualize vasculature within native liver cyst walls of human ADPKD patients

Measuring quality of life in patients with hereditary kidney disease

Measuring quality of life in patients with hereditary kidney disease

MRI provides an early alert for polycystic kidney disease

MRI provides an early alert for polycystic kidney disease